ConductScience.org, home

Paper73643

Mitochondrial calcium overload: A general mechanism for cell-necrosis in muscle diseases.

Wrogemann K and 1 other. Lancet, 1976. Cited by 460 papers, by iCite.

Cite this record

ConductScience Library. Mitochondrial calcium overload: A general mechanism for cell-necrosis in muscle diseases. Papers, record 73643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/73643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mitochondrial calcium overload: A general mechanism for cell-necrosis in muscle diseases.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
460
iCite
Relative citation ratio, by iCite
14.3
iCite
Revised in PubMed
2022-03-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wrogemann KK
2Pena SDS D

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CalciumMajor topic
Mitochondria, MuscleMajor topic
MusclesMajor topic
Muscular DystrophiesMajor topic
Humans
Models, Biological
Necrosis
Oxidative Phosphorylation

Source PubMed

Download CSV of topics

Cited by100

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 460 citations.

PMIDTitleJournalYearIn PapersSource
42352253Targeting Oxidative Stress and Inflammation in Pembrolizumab-Induced Renal Injury: A Comparative Evaluation of the Protective Effects of Flunarizine and Carvacrol in Rats.Biomolecules2026https://conductscience.org/library/papers/42352253PubMed
41742249Role of mitochondrial dysfunction in muscle wasting in cancer cachexia: a narrative review.J Transl Med2026https://conductscience.org/library/papers/41742249PubMed
41113295Rhabdomyolysis Induced by Irbesartan-Hydrochlorothiazide in an Elderly Patient.Clin Case Rep2025https://conductscience.org/library/papers/41113295PubMed
40321007Perspectives on the interpretation of mitochondrial responses during skeletal muscle disuse-induced atrophy.J Physiol2025https://conductscience.org/library/papers/40321007PubMed
39321180Ultrastructural changes in cardiac and skeletal myoblasts following in vitro exposure to monensin, salinomycin, and lasalocid.PLoS One2024https://conductscience.org/library/papers/39321180PubMed
39056750Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response.Cells2024https://conductscience.org/library/papers/39056750PubMed
38371826New Pathophysiological Insights from Serum Proteome Profiling in Equine Atypical Myopathy.ACS Omega2024https://conductscience.org/library/papers/38371826PubMed
37737731Calcium handling dysfunction and cardiac damage following acute ventricular preload challenge in the dystrophin-deficient mouse heart.Am J Physiol Heart Circ Physiol2023https://conductscience.org/library/papers/37737731PubMed
37460667Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directions.Cell Death Differ2023https://conductscience.org/library/papers/37460667PubMed
36265896Dlk1-Dio3 cluster miRNAs regulate mitochondrial functions in the dystrophic muscle in Duchenne muscular dystrophy.Life Sci Alliance2023https://conductscience.org/library/papers/36265896PubMed
35208266The Role of Taurine in Skeletal Muscle Functioning and Its Potential as a Supportive Treatment for Duchenne Muscular Dystrophy.Metabolites2022https://conductscience.org/library/papers/35208266PubMed
34579193Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination.Vaccines (Basel)2021https://conductscience.org/library/papers/34579193PubMed
34533019A revised model for mitochondrial dysfunction in Duchenne muscular dystrophy.Eur J Transl Myol2021https://conductscience.org/library/papers/34533019PubMed
34298968Skeletal Muscle Mitochondria Dysfunction in Genetic Neuromuscular Disorders with Cardiac Phenotype.Int J Mol Sci2021https://conductscience.org/library/papers/34298968PubMed
33995132Looking Back to the Future of Mitochondrial Research.Front Physiol2021https://conductscience.org/library/papers/33995132PubMed
33733717Translational research on Myology and Mobility Medicine: 2021 semi-virtual PDM3 from Thermae of Euganean Hills, May 26 - 29, 2021.Eur J Transl Myol2021https://conductscience.org/library/papers/33733717PubMed
33489533A Case of Methyl Ethyl Ketone Peroxide Ingestion Complicated by Rhabdomyolysis.Cureus2020https://conductscience.org/library/papers/33489533PubMed
32499563miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy.Sci Rep2020https://conductscience.org/library/papers/32499563PubMed
31661602Tracking intra- and inter-organelle signaling of mitochondria.FEBS J2019https://conductscience.org/library/papers/31661602PubMed
31574188CRISPR/Cas9-Based Dystrophin Restoration Reveals a Novel Role for Dystrophin in Bioenergetics and Stress Resistance of Muscle Progenitors.Stem Cells2019https://conductscience.org/library/papers/31574188PubMed

See all 100 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/73643

GET https://conductscience.org/api/papers/v1/73643/cited_by?page=2